Kidney Transplantation and Transplant Immunology 6

8 Feb 2025 5:30 p.m. 6:30 p.m.

Time	Session

12 a.m. 12 a.m.	CYP3A5 POLYMORPHISM AND TACROLIMUS CONCENTRATION IN INDIAN RENAL TRANSPLANT RECIPIENTS WCN25-AB-2900, Poster Board= SAT-419	IMPACT OF HIGH DIABETES MELLITUS PREVALENCE ON KIDNEY TRANSPLANTATION IN MAURITIUS WCN25-AB-4186, Poster Board= SAT-420	AN OBSERVATIONAL STUDY OF C/D RATIO TO PREDICT CYP3A5 GENOTYPE POLYMORPHISM AND TACROLIMUS METABOLISM IN INDIAN RENAL TRANSPLANT PATIENTS WCN25-AB-3015, Poster Board= SAT-421	TACROLIMUS ASSOCIATED POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME (PRES) IN EARLY POST-TRANSPLANT PERIOD IN PATIENT OF BARDET-BIEDL SYNDROME: A RAREST OF RARE CASE WCN25-AB-3031, Poster Board= SAT-422	UNTOLD STORY OF LIVING KIDNEY DONORS OF BANGLADESH:AN OBSERVATIONAL STUDY WCN25-AB-3127, Poster Board= SAT-423	FLOZINATION IN KIDNEY TRANSPLANT RECIPIENTS: IS IT SAFE? WCN25-AB-3301, Poster Board= SAT-424	INCIDENCE OF DENOVO HLA ANTIBODIES - CORRELATION WITH EPLET MISMATCH LOAD AND GRAFT OUTCOME; A SINGLE CENTRE STUDY WCN25-AB-3302, Poster Board= SAT-425	A NATIONWIDE SURVEY ON BARRIERS TO ORGAN DONATION IN INDIA : CALL FOR ACTION WCN25-AB-3337, Poster Board= SAT-426	SAFETY OF LOW DOSE ACE INHIBITION IN LIVING KIDNEY DONORS : A PILOT STUDY WCN25-AB-3766, Poster Board= SAT-427	LONG TERM OUTCOME OF KETOCONAZOLE AUGMENTED TACROLIMUS IN KIDNEY TRANSPLANT PATIENTS (KATE) WCN25-AB-3987, Poster Board= SAT-428	ASSOCIATION BETWEEN TACROLIMUS TROUGH LEVEL AND INCIDENCE OF NEW ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION WCN25-AB-4313, Poster Board= SAT-429	STEROID AVOIDANCE WITH LOW-DOSE TACROLIMUS IS SAFE AND EFFECTIVE FOR KIDNEY TRANSPLANT RECIPIENTS WITH LOW IMMUNOLOGIC RISK IN THE LONG-TERM: SAILOR II FOLLOW-UP STUDY WCN25-AB-3638, Poster Board= SAT-430	BK VIRUS NEPHROPATHY AND TRANSPLANT OUTCOMES - A SINGLE CENTER STUDY WCN25-AB-4432, Poster Board= SAT-431	IMPACT OF HLA SENSITIZATION ON PATIENT AND GRAFT OUTCOMES IN ABO-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATIONS WCN25-AB-3637, Poster Board= SAT-432	OUTCOME OF KIDNEY TRANSPLANTS FROM HEPATITIS C VIREMIC DONORS TO HEPATITIS C NEGATIVE RECIPIENTS: REPORT FROM DOWN UNDER WCN25-AB-4144, Poster Board= SAT-433	OUTCOMES OF KIDNEY TRANSPLANT FROM HEPATITIS C NUCLEIC ACID AMPLIFICATION TEST POSITIVE DONORS: A SINGLE CENTER EXPERIENCE WCN25-AB-3770, Poster Board= SAT-434	USE OF GRAFALON (R-ATLG) AND THYMOGLOBULIN (R-ATG) AS INDUCTION IN ABO-INCOMPATIBLE TRANSPLANT RECIPIENTS WITH ANTI-HLA SENSITIZATION WCN25-AB-3854, Poster Board= SAT-435	OUTCOMES OF MODIFIED M-HEALTH INSTRUCTIONS FOR SELF-CARE AFTER RENAL TRANSPLANTATION WCN25-AB-3830, Poster Board= SAT-436	COMPARATIVE ANALYSIS OF ELECTROLYTE TRENDS AND BIOCHEMICAL PARAMETERS IN CHRONIC CALCINEURIN INHIBITOR TOXICITY AND T-CELL MEDIATED REJECTION IN RENAL TRANSPLANT PATIENTS WCN25-AB-3916, Poster Board= SAT-437	TRANSPLANT RENAL ARTERY STENOSIS: A SINGLE CENTRE STUDY WCN25-AB-3874, Poster Board= SAT-438	CLINICAL PROFILE OF RENAL ALLOGRAFT RECIPIENTS SWITCHED TO MTOR INHIBITOR-BASED REGIMEN FROM TACROLIMUS AND MYCOPHENOLATE BASED REGIMENS: A SINGLE-CENTER RETROSPECTIVE OBSERVATIONAL STUDY WCN25-AB-3889, Poster Board= SAT-439	TRANSPLANT OUTCOMES IN PATIENTS WITH PRIMARY FSGS: A SINGLE CENTRE EXPERIENCE WCN25-AB-4287, Poster Board= SAT-440	EFFACED BUT NOT ERASED - A CASE OF CONSECUTIVE RELAPSES OF LUPUS PODOCYTOPATHY IN RENAL TRANSPLANTS WCN25-AB-3992, Poster Board= SAT-441